165 related articles for article (PubMed ID: 9773717)
1. The Veterans Affairs Implantable Insulin Pump Study: effect on cardiovascular risk factors.
Duckworth WC; Saudek CD; Giobbie-Hurder A; Henderson WG; Henry RR; Kelley DE; Edelman SV; Zieve FJ; Adler RA; Anderson JW; Anderson RJ; Hamilton BP; Donner TW; Kirkman MS; Morgan NA
Diabetes Care; 1998 Oct; 21(10):1596-602. PubMed ID: 9773717
[TBL] [Abstract][Full Text] [Related]
2. Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group.
Saudek CD; Duckworth WC; Giobbie-Hurder A; Henderson WG; Henry RR; Kelley DE; Edelman SV; Zieve FJ; Adler RA; Anderson JW; Anderson RJ; Hamilton BP; Donner TW; Kirkman MS; Morgan NA
JAMA; 1996 Oct 23-30; 276(16):1322-7. PubMed ID: 8861991
[TBL] [Abstract][Full Text] [Related]
3. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
[TBL] [Abstract][Full Text] [Related]
4. Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial.
Aronson R; Reznik Y; Conget I; Castañeda JA; Runzis S; Lee SW; Cohen O;
Diabetes Obes Metab; 2016 May; 18(5):500-7. PubMed ID: 26854123
[TBL] [Abstract][Full Text] [Related]
5. Complex Assessment of Metabolic Effectiveness of Insulin Pump Therapy in Patients with Type 2 Diabetes Beyond HbA1c Reduction.
Chlup R; Runzis S; Castaneda J; Lee SW; Nguyen X; Cohen O
Diabetes Technol Ther; 2018 Feb; 20(2):153-159. PubMed ID: 29215299
[TBL] [Abstract][Full Text] [Related]
6. Effects of multiple daily insulin injections and intraperitoneal insulin therapy on cholesteryl ester transfer and lipoprotein lipase activities in NIDDM.
Bagdade JD; Kelley DE; Henry RR; Eckel RH; Ritter MC
Diabetes; 1997 Mar; 46(3):414-20. PubMed ID: 9032097
[TBL] [Abstract][Full Text] [Related]
7. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
[TBL] [Abstract][Full Text] [Related]
8. Use of insulin pump therapy in patients with type 2 diabetes after failure of multiple daily injections.
Leinung MC; Thompson S; Luo M; Leykina L; Nardacci E
Endocr Pract; 2013; 19(1):9-13. PubMed ID: 22982794
[TBL] [Abstract][Full Text] [Related]
9. A comparison of multiple daily insulin therapy with continuous subcutaneous insulin infusion therapy in adolescents with type 1 diabetes mellitus: a single-center experience from Turkey.
Abaci A; Atas A; Unuvar T; Demir K; Bober E; Büyükgebiz A
J Pediatr Endocrinol Metab; 2009 Jun; 22(6):539-45. PubMed ID: 19694201
[TBL] [Abstract][Full Text] [Related]
10. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.
Hanaire-Broutin H; Melki V; Bessières-Lacombe S; Tauber JP
Diabetes Care; 2000 Sep; 23(9):1232-5. PubMed ID: 10977011
[TBL] [Abstract][Full Text] [Related]
11. Effects of insulin therapy with continuous subcutaneous insulin infusion (CSII) in diabetic patients: comparison with multi-daily insulin injections therapy (MDI).
Derosa G; Maffioli P; D'Angelo A; Salvadeo SA; Ferrari I; Fogari E; Mereu R; Gravina A; Palumbo I; Randazzo S; Cicero AF
Endocr J; 2009; 56(4):571-8. PubMed ID: 19352055
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study.
Conget I; Castaneda J; Petrovski G; Guerci B; Racault AS; Reznik Y; Cohen O; Runzis S; de Portu S; Aronson R;
Diabetes Technol Ther; 2016 Jan; 18(1):22-8. PubMed ID: 26241790
[TBL] [Abstract][Full Text] [Related]
13. IMPROVED HBA1C, TOTAL DAILY INSULIN DOSE, AND TREATMENT SATISFACTION WITH INSULIN PUMP THERAPY COMPARED TO MULTIPLE DAILY INSULIN INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES IRRESPECTIVE OF BASELINE C-PEPTIDE LEVELS.
Vigersky RA; Huang S; Cordero TL; Shin J; Lee SW; Chhabra H; Kaufman FR; Cohen O;
Endocr Pract; 2018 May; 24(5):446-452. PubMed ID: 29847166
[TBL] [Abstract][Full Text] [Related]
14. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
Chow CC; Tsang LW; Sorensen JP; Cockram CS
Diabetes Care; 1995 Mar; 18(3):307-14. PubMed ID: 7555472
[TBL] [Abstract][Full Text] [Related]
15. Effects of combination of insulin and acarbose compared with insulin and gliclazide in type 2 diabetic patients.
Güvener N; Gedik O
Acta Diabetol; 1999 Jun; 36(1-2):93-7. PubMed ID: 10436259
[TBL] [Abstract][Full Text] [Related]
16. Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin.
Reid LJ; Gibb FW; Colhoun H; Wild SH; Strachan MWJ; Madill K; Dhillon B; Forbes S
Diabetologia; 2021 Aug; 64(8):1725-1736. PubMed ID: 33966091
[TBL] [Abstract][Full Text] [Related]
17. Continuous subcutaneous insulin infusion in patients with type 2 diabetes: a cohort study to establish the relationship between glucose control and plasma oxidized low density lipoprotein.
Megson IL; Treweeke AT; Shaw A; MacRury SM; Setford S; Frias JP; Anhalt H
J Diabetes Sci Technol; 2015 May; 9(3):573-80. PubMed ID: 25652563
[TBL] [Abstract][Full Text] [Related]
18. OpT2mise: a randomized controlled trial to compare insulin pump therapy with multiple daily injections in the treatment of type 2 diabetes-research design and methods.
Aronson R; Cohen O; Conget I; Runzis S; Castaneda J; de Portu S; Lee S; Reznik Y;
Diabetes Technol Ther; 2014 Jul; 16(7):414-20. PubMed ID: 24735134
[TBL] [Abstract][Full Text] [Related]
19. Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study.
Alderisio A; Bozzetto L; Franco L; Riccardi G; Rivellese AA; Annuzzi G
Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1110-1117. PubMed ID: 31371264
[TBL] [Abstract][Full Text] [Related]
20. Glyco-metabolic control, inflammation markers, and cardiovascular outcomes in type 1 and type 2 diabetic patients on insulin pump or multiple daily injection (italico study).
Derosa G; Catena G; Scelsi L; D'Angelo A; Raddino R; Cosentino E; Maggi A; Pasini G; Borghi C; Maffioli P
Diabetes Metab Res Rev; 2020 Jan; 36(1):e3219. PubMed ID: 31642581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
